Summary
The effects of Ro 12-4713, a vasodilator, on blood pressure and heart rate, were tested in 13 ambulant patients with mild to severe hypertension. The patients received Ro 12-4713 in total oral doses ranging from 1.5 to 4 mg/kg over a 3–5 day period. Standard laboratory tests were done 24 h before and after the study. Standing and supine blood pressure and heart rate were determined before, and every hour for 6–8 h after drug administration. ECGs were recorded before, during and at the end of each study day. Ro 12-4713 reduced the pretreatment standing and supine blood pressure from 213±34 / 126± 21 mmHg and 218±31 / 130±20 mmHg to 156± 33 / 85±9 mmHg and 158±25 / 88±11 mmHg at the end of Day 5. Heart rate was only transiently increased in patients with pretreatment values of <90 beats/min. Although abnormal ECGs tended towards normalization, there were 2 cases of T-wave inversion (the patients remained asymptomatic). Raised BUN levels tended to decrease towards normal. Side effects reported spontaneously by patients (headaches, palpitations, dizziness, nausea and one case of water retention) appeared to be transient in nature. Ro 12-4713 appeared to be a very potent and long lasting antihypertensive agent, whose inherent side effects were only transient in nature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Campese VM, Stein D, DeQuattro V (1979) Treatment of severe hypertension with minoxidil: Advantages and limitations. J Clin Pharmacol 19: 231–241
Chidsey CA, Gottlieb TB, Pluss RG, Orcutt JC, Weil JV (1973) The use of vasodilators and beta-adrenergic blockade in hypertension. In: Onesti G, Kim KE, Moyer JH (eds) Hypertension: Mechanisms and management. Hahneman Symposium. Grune and Stratton, New York, pp 289–297
Dargie HJ, Dollery CT, Daniel J (1977) Minoxidil in resistant hypertension. Lancet 2: 515–518
Epstein SE, Redwood DR, Goldstein RE et al. (1971) Angina pectoris: Pathophysiology, evaluation and treatment. Ann Intern Med 75: 263–296
Gerold M, Eigenmann R, Hefti F, Daum A, Häusler G (1980) The pharmacology of a new vasodilator. J Pharmacol Exp Ther (in press)
Gilmore E, Weil J, Chidsey C (1970) Treatment of essential hypertension with a new vasodilator in combination withβ-adrenergic blockade. N Engl J Med 282: 521–527
Gottlieb TB, Katz FH, Chidsey CA (1972) Combined therapy with vasodilator drugs andβ-adrenergic blockade in hypertension. Circulation 45: 571–582
Hall D, Charocopos F, Froer KL, Rudolph W (1978) Use of minoxidil in resistant hypertension. Herz 3: 313–324
Kanada SA, Kanada DJ, Hutchinson RA, Du D (1976) Angina-like syndrome with diazoxide therapy for hypertensive crisis. Ann Intern Med 84: 696–699
Koch-Weser J (1974) Vasodilator drugs in the treatment of hypertension. Arch Intern Med 133: 1017–1027
Lepeschkin E (1976) Physiological influences on transfer factors between heart currents and body-surface potentials. In: Nelson CV, Geselowitz DB (eds) The theoretical basis of electrocardiology. Clarendon Press, Oxford, pp 135–161
Lowenthal DT, Onesti G, Mutterperl R, Affrime M, Martinez EW, Kim KE, Busby P, Shirk J, Swartz C (1978) Long-term clinical effects, bioavailability and kinetics of minoxidil in relation to renal function. J Clin Pharmacol 18: 500–508
Mutterperl R, Diamond FB, Lowenthal DT (1976) Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure. J Clin Pharmacol 16: 498–509
Moyer JH (1953) Hydrallazine (Apresoline) hydrochloride: Pharmacological observations and clinical results in the therapy of hypertension. AMA Arch Intern Med 91: 419–439
Pruitt RD, Klakeg CH, Chapin LE (1955) Certain clinical states and pathologic changes associated with deeply intervented T-waves in the precordial electrocardiograms. Circulation 11: 517–530
Sannerstedt R, Brorson L, Berglund G, Werkö L (1975) Minoxidil — haemodynamic and clinical experiences with a new peripheral vasodilator. Acta Med Scand 197: 409–414
WHO (1978) Arterial hypertension. Technical Report Series 628: 9–11
Zacest R, Frewin DB, Robinson MA, Wilson LL, Lawrence JR, Jackson B (1976) Clinical and haemodynamic effects of minoxidil in refractory hypertension. Drugs 11 (Suppl 1): 177–184
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chu, D., Cocco, G., Strozzi, C. et al. Antihypertensive effects of a novel peripheral vasodilator, Ro 12-4713. Eur J Clin Pharmacol 19, 233–238 (1981). https://doi.org/10.1007/BF00562798
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562798